References
- Anastasiou D, Yu Y, Israelsen WJ, Jiang JK, Boxer MB, Hong BS, et al. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat Chem Biol 2012; 8:839 - 47; http://dx.doi.org/10.1038/nchembio.1060; PMID: 22922757
- Dang CV. MYC on the path to cancer. Cell 2012; 149:22 - 35; http://dx.doi.org/10.1016/j.cell.2012.03.003; PMID: 22464321
- Austin WR, Armijo AL, Campbell DO, Singh AS, Hsieh T, Nathanson D, et al. Nucleoside salvage pathway kinases regulate hematopoiesis by linking nucleotide metabolism with replication stress. J Exp Med 2012; 209:2215 - 28; http://dx.doi.org/10.1084/jem.20121061; PMID: 23148236
- Gerriets VA, Rathmell JC. Metabolic pathways in T cell fate and function. Trends Immunol 2012; 33:168 - 73; http://dx.doi.org/10.1016/j.it.2012.01.010; PMID: 22342741
- van der Windt GJ, Pearce EL. Metabolic switching and fuel choice during T-cell differentiation and memory development. Immunol Rev 2012; 249:27 - 42; http://dx.doi.org/10.1111/j.1600-065X.2012.01150.x; PMID: 22889213
- Waickman AT, Powell JD. mTOR, metabolism and the regulation of T-cell differentiation and function. Immunol Rev 2012; 249:43 - 58; http://dx.doi.org/10.1111/j.1600-065X.2012.01152.x; PMID: 22889214
- Amiel E, Everts B, Freitas TC, King IL, Curtis JD, Pearce EL, et al. Inhibition of mechanistic target of rapamycin promotes dendritic cell activation and enhances therapeutic autologous vaccination in mice. J Immunol 2012; 189:2151 - 8; http://dx.doi.org/10.4049/jimmunol.1103741; PMID: 22826320
- Finlay DK, Rosenzweig E, Sinclair LV, Feijoo-Carnero C, Hukelmann JL, Rolf J, et al. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J Exp Med 2012; 209:2441 - 53; http://dx.doi.org/10.1084/jem.20112607; PMID: 23183047
- Gattinoni L, Klebanoff CA, Restifo NP. Paths to stemness: building the ultimate antitumour T cell. Nat Rev Cancer 2012; 12:671 - 84; http://dx.doi.org/10.1038/nrc3322; PMID: 22996603